Galmed Pharmaceuticals
GLMD
22 hedge funds and large institutions have $8.36M invested in Galmed Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 4 closing their positions.
0% more funds holding
Funds holding: 22 → 22 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
6% less capital invested
Capital invested by funds: $8.93M → $8.36M (-$575K)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$87K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$36.5K |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$36.5K |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$19.1K |
| 5 |
Morgan Stanley
New York
|
+$6.96K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAD
Craig A. Drill
|
-$904K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$121K |
| 3 |
SIM
Spark Investment Management
New York
|
-$111K |
| 4 |
Renaissance Technologies
New York
|
-$59.1K |
| 5 |
Goldman Sachs
New York
|
-$52.2K |
GLMD Hedge Fund Activity: Q2 2015 in Review
22 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Galmed Pharmaceuticals (GLMD) for Q2 2015, worth a combined $8.36M — down 6.4% from $8.93M a quarter earlier.
Fund positioning in GLMD was balanced in Q2 2015: 4 funds opened new positions, 4 closed out, 4 added to existing stakes and 6 trimmed.
The largest buyer was Vanguard Group, adding an estimated $87K. The largest seller was Craig A. Drill, cutting an estimated $904K.
- 22 institutional investors held Galmed Pharmaceuticals (GLMD) as of Q2 2015, unchanged from Q1 2015.
- Funds reported $8.36M of Galmed Pharmaceuticals stock for Q2 2015, down 6.4% quarter-over-quarter.
- 4 funds opened new Galmed Pharmaceuticals positions in Q2 2015 and 4 closed out, a net change of 0 holders.
- The largest Galmed Pharmaceuticals buyer in Q2 2015 was Vanguard Group, an estimated $87K added.
- The largest Galmed Pharmaceuticals seller in Q2 2015 was Craig A. Drill, an estimated $904K sold.
Based on aggregated 13F filings for Q2 2015.